2x Faster Clinical Trial Recruitment
Cosign AI (co-sign.ai) earns a Brand Analyzer score of 77 out of 100, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, Cosign AI ranks in the 92nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 95/100, Digital Presence 82/100, Visual Identity 96/100, Messaging Clarity 95/100, Trust Foundation 73/100, AI Discoverability 71/100, Brand Authority 48/100.
Cosign AI (co-sign.ai) is a healthcare SaaS platform designed to accelerate clinical trial recruitment through real-time electronic health record (EHR) integration. The platform screens approximately 3,000 patients weekly across nine sites with a reported 97% accuracy rate. It aims to deliver 2x faster recruitment and over $60 million in operational savings per trial. Its stated mission is to bring breakthrough science to patients sooner by identifying eligible trial participants at the point of care without disrupting clinical workflows.
| Brand Name | Cosign AI |
|---|---|
| Domain | co-sign.ai |
| Industry | Healthcare, SaaS |
| Main Competitors | Medidata Solutions, Veeva Systems (81/100), Science 37, Antidote, TriNetX, Elligo Health Research |
Moz Domain Authority 9/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Cosign AI has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Cosign AI - Drive 2x faster clinical trial recruitment with real-time EHR integration. 97% accuracy across 9 sites, screening 3,000 patients weekly. $60M+ operational savings per t…" (Meta description: 27 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Cosign AI scores 45/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cosign AI has a limited AI-visibility profile at 45/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (55/100) and its weakest is trust (24/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 9/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cosign AI's main competitors include Medidata Solutions, Veeva Systems (81/100), Science 37, Antidote, TriNetX. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Cosign AI official site
Cosign AI and Veeva Systems are competitors in Healthcare. Brand Analyzer scores Cosign AI at 77/100 and Veeva Systems at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Cosign AI official site
Popular alternatives to Cosign AI include Medidata Solutions, Veeva Systems (81/100), Science 37, Antidote, TriNetX. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Cosign AI official site
Cosign AI has limited AI-search visibility, scoring 45/100 on Brand Analyzer's AI visibility composite (visibility 55, trust 24, recommendation 51). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cosign AI official site
Cosign AI identifies eligible patients for clinical trials by integrating directly with electronic health record (EHR) systems in real time. It screens thousands of patients weekly - approximately 3,000 - across nine sites without disrupting existing clinical workflows. The platform is reported to deliver 2x faster recruitment compared to conventional methods and generate over $60 million in operational savings per trial. It targets the point of care, enabling clinical investigators and research sites to find qualified trial participants more efficiently.
Sources: Cosign AI official site
Cosign AI is a healthcare SaaS platform that positions itself as a leading AI solution for accelerating clinical trial recruitment at the point of care. It integrates with electronic health record (EHR) systems in real time to identify eligible patients for clinical trials. The platform operates across nine sites, screens approximately 3,000 patients weekly, and reports a 97% accuracy rate. Its stated mission is to bring breakthrough science to patients sooner by removing delays in the trial recruitment process.
Sources: Cosign AI official site
Cosign AI scores 51/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Cosign AI official site
Based on the known facts, Cosign AI offers a SaaS-based AI platform for clinical trial patient recruitment that operates through real-time electronic health record (EHR) integration. The platform screens patients against trial eligibility criteria at the point of care, covering approximately 3,000 patients weekly across nine sites. No additional discrete product lines, modules, or named service tiers are described in the available information beyond this core recruitment and screening solution.
Sources: Cosign AI official site
Cosign AI is known for its real-time EHR integration for clinical trial patient identification, a reported 97% screening accuracy rate, and the ability to screen approximately 3,000 patients weekly across nine sites. It is also recognized for delivering 2x faster clinical trial recruitment and over $60 million in operational savings per trial. Its focus on point-of-care patient identification without disrupting clinical workflows distinguishes it within the clinical trial recruitment space.
Sources: Cosign AI official site
Cosign AI can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cosign AI official site
According to the known facts, Cosign AI's target audience consists of clinical investigators, research sites, and clinical trial sponsors who face recruitment delays. These are professionals and organizations directly involved in the planning, execution, and oversight of clinical trials. Research sites using EHR systems are specifically relevant users, as the platform's core functionality depends on real-time EHR integration to identify and screen eligible patients at the point of care.
Sources: Cosign AI official site
Ranked closest to Cosign AI: ClearDent (77/100), Chartwell Retirement Residences (77/100), Cradlewise (77/100), Cureus (77/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).